NASDAQ:PROF Profound Medical (PROF) Stock Price, News & Analysis → Write this ticker symbol down… (From StocksToTrade) (Ad) Free PROF Stock Alerts $8.18 +0.17 (+2.12%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share Today's Range$8.01▼$8.2150-Day Range$7.25▼$8.5452-Week Range$7.11▼$15.49Volume13,900 shsAverage Volume37,015 shsMarket Capitalization$199.84 millionP/E RatioN/ADividend YieldN/APrice Target$14.58 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Profound Medical alerts: Email Address Profound Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside78.3% Upside$14.58 Price TargetShort InterestHealthy1.20% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.11) to ($0.97) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.41 out of 5 starsMedical Sector675th out of 903 stocksSurgical & Medical Instruments Industry78th out of 98 stocks 3.5 Analyst's Opinion Consensus RatingProfound Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageProfound Medical has received no research coverage in the past 90 days.Read more about Profound Medical's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.20% of the outstanding shares of Profound Medical have been sold short.Short Interest Ratio / Days to CoverProfound Medical has a short interest ratio ("days to cover") of 9.Change versus previous monthShort interest in Profound Medical has recently decreased by 5.71%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldProfound Medical does not currently pay a dividend.Dividend GrowthProfound Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PROF. Previous Next 0.0 News and Social Media Coverage MarketBeat FollowsOnly 1 people have added Profound Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Profound Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.52% of the stock of Profound Medical is held by insiders.Percentage Held by Institutions47.86% of the stock of Profound Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Profound Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Profound Medical are expected to grow in the coming year, from ($1.11) to ($0.97) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Profound Medical is -6.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Profound Medical is -6.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioProfound Medical has a P/B Ratio of 6.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Profound Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution About Profound Medical Stock (NASDAQ:PROF)Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.Read More PROF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PROF Stock News HeadlinesMay 16, 2024 | finanznachrichten.deProfound Medical Corp.: Profound Medical Annual General Meeting of Shareholders Voting ResultsMay 15, 2024 | globenewswire.comProfound Medical Annual General Meeting of Shareholders Voting ResultsMay 15, 2024 | finance.yahoo.comPROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTSMay 14, 2024 | msn.comProfound wins FDA clearance for AI support to Tulsa systemMay 14, 2024 | msn.comProfound Medical gets FDA okay for TULSA AI moduleMay 14, 2024 | financialpost.comProfound Medical Receives U.S. FDA 510(k) Clearance for 'Contouring Assistant' AI Module that Enables Creation of an Automated TULSA Treatment PlanMay 14, 2024 | finance.yahoo.comProfound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment PlanMay 14, 2024 | globenewswire.comProfound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant' AI Module that Enables Creation of an Automated TULSA Treatment PlanMay 9, 2024 | markets.businessinsider.comProfound Medical is about to announce its earnings — here's what to expectMay 6, 2024 | globenewswire.comGrowing Body of Clinical Evidence Points to the Potential of Profound Medical's TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease SpectrumMay 3, 2024 | finance.yahoo.comIn the wake of Profound Medical Corp.'s (TSE:PRN) latest CA$31m market cap drop, institutional owners may be forced to take severe actionsApril 30, 2024 | finance.yahoo.comPrebys Foundation Announces $7 Million "Prebys Research Heroes" Program to Improve Medical Research through DiversityApril 30, 2024 | msn.comRussell Brand says he’s been ‘changed’ by baptism after sexual assault allegations: ‘Profound experience’April 30, 2024 | msn.comMet police officer who punched medical worker spared jailApril 27, 2024 | msn.comResearch shows 'profound' link between dietary choices and brain healthApril 23, 2024 | msn.comEastern Band of Cherokee Indians Opens North Carolina's First And Only Medical Marijuana Dispensary On 4/20April 22, 2024 | globenewswire.comProfound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to FollowApril 21, 2024 | markets.businessinsider.comIntroducing the Inaugural Dr. Ameer Hassan Scholarship for Medical Students: Pioneering Excellence in Neurology and HealthcareApril 19, 2024 | businesswire.comDr. Cathleen Brown Named Medical Director of Winona, Pioneering Menopause Telehealth CompanyApril 18, 2024 | yahoo.com'Keep him alive': Survivors, Memorial Medical Center salute organ donorsApril 18, 2024 | msn.comMedical Mall Wellness Center Set to Close | April 17, 2024 | News 19 at 6 p.m.April 17, 2024 | finanznachrichten.deAccuryn Medical Announces Leadership TransitionApril 17, 2024 | msn.com'Vibrant Spirit': Hit-And-Run Death Of Ridgefield Teen Leaves 'Profound Void' In 2 CommunitiesApril 14, 2024 | yahoo.comThe story of love and the challenges faced after a profound medical diagnosisApril 14, 2024 | markets.businessinsider.comIntroducing the Dr. Tyrone Malloy Scholarship for Medical Students: Nurturing Tomorrow's Leaders in Women's HealthSee More Headlines Receive PROF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today6/10/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:PROF CUSIPN/A CIK1628808 Webwww.profoundmedical.com Phone(647) 476-1350Fax64-7847-3739Employees131Year FoundedN/APrice Target and Rating Average Stock Price Target$14.58 High Stock Price Target$20.00 Low Stock Price Target$11.00 Potential Upside/Downside+78.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-28,570,000.00 Net Margins-386.63% Pretax Margin-388.52% Return on Equity-70.08% Return on Assets-53.76% Debt Debt-to-Equity RatioN/A Current Ratio5.41 Quick Ratio4.73 Sales & Book Value Annual Sales$7.20 million Price / Sales27.76 Cash FlowN/A Price / Cash FlowN/A Book Value$1.28 per share Price / Book6.39Miscellaneous Outstanding Shares24,430,000Free Float24,058,000Market Cap$199.84 million OptionableOptionable Beta0.82 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Arun Swarup Menawat MBA (Age 69)Ph.D., Chairman of the Board & CEO Comp: $435.87kMr. Rashed Dewan (Age 56)Chief Financial Officer Comp: $215.18kDr. Mathieu Burtnyk (Age 42)Chief Operating Officer Comp: $215.18kMr. Hartmut Warnken (Age 51)Chief Commercial Officer of Outside US Comp: $226.17kMs. Abbey Goodman (Age 41)Chief Commercial Officer of US Comp: $374.35kMr. Stephen KilmerInvestor RelationsMr. Jacques F. Cornet (Age 68)Senior VP & Product Leader Sonalleve Mr. Matthew Sobczyk C.A.CPA, Assistant Corporate ControllerMr. Levant TinazSoftware DeveloperMore ExecutivesKey CompetitorsSurmodicsNASDAQ:SRDXParagon 28NYSE:FNASI-BONENASDAQ:SIBNIradimedNASDAQ:IRMDBioventusNYSE:BVSView All CompetitorsInstitutional OwnershipSilvercrest Asset Management Group LLCSold 52,000 shares on 5/16/2024Ownership: 0.061%Gagnon Securities LLCSold 12,539 shares on 5/14/2024Ownership: 6.259%Gagnon Advisors LLCBought 67,930 shares on 5/14/2024Ownership: 3.059%Zweig DiMenna Associates LLCSold 26,356 shares on 4/29/2024Ownership: 0.427%Raymond James Financial Services Advisors Inc.Bought 2,913 shares on 4/23/2024Ownership: 2.560%View All Institutional Transactions PROF Stock Analysis - Frequently Asked Questions Should I buy or sell Profound Medical stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Profound Medical in the last year. There are currently 1 hold rating, 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" PROF shares. View PROF analyst ratings or view top-rated stocks. What is Profound Medical's stock price target for 2024? 3 Wall Street analysts have issued 1-year price objectives for Profound Medical's shares. Their PROF share price targets range from $11.00 to $20.00. On average, they expect the company's share price to reach $14.58 in the next year. This suggests a possible upside of 78.3% from the stock's current price. View analysts price targets for PROF or view top-rated stocks among Wall Street analysts. How have PROF shares performed in 2024? Profound Medical's stock was trading at $8.49 at the start of the year. Since then, PROF stock has decreased by 3.7% and is now trading at $8.18. View the best growth stocks for 2024 here. When is Profound Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our PROF earnings forecast. How were Profound Medical's earnings last quarter? Profound Medical Corp. (NASDAQ:PROF) released its quarterly earnings data on Thursday, May, 9th. The company reported ($0.26) EPS for the quarter, beating analysts' consensus estimates of ($0.31) by $0.05. The company had revenue of $1.91 million for the quarter, compared to analyst estimates of $2.40 million. Profound Medical had a negative trailing twelve-month return on equity of 70.08% and a negative net margin of 386.63%. What guidance has Profound Medical issued on next quarter's earnings? Profound Medical issued an update on its FY 2024 earnings guidance on Thursday, May, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $11.0 million-$12.0 million, compared to the consensus revenue estimate of $11.6 million. Who are Profound Medical's major shareholders? Profound Medical's stock is owned by many different institutional and retail investors. Top institutional investors include Gagnon Securities LLC (6.26%), Gagnon Advisors LLC (3.06%), Raymond James Financial Services Advisors Inc. (2.56%), Zweig DiMenna Associates LLC (0.43%) and Silvercrest Asset Management Group LLC (0.06%). How do I buy shares of Profound Medical? Shares of PROF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PROF) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.